Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 9457387)

Published in Cancer J Sci Am on December 01, 1997

Authors

S S Legha1, S Ring, O Eton, A Bedikian, C Plager, N Papadopoulos

Author Affiliations

1: Melanoma Section, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

Articles by these authors

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (1997) 15.48

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell (1993) 9.93

A public database for gene expression in human cancers. Cancer Res (1999) 8.81

The molecular basis of Turcot's syndrome. N Engl J Med (1995) 6.65

Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell (1993) 6.61

Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (1994) 6.21

Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87

Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci U S A (2007) 4.27

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet (2002) 3.67

Conversion of diploidy to haploidy. Nature (2000) 3.28

Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07

Deletion of p16 and p15 genes in brain tumors. Cancer Res (1994) 3.03

Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62

CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat Genet (1999) 2.60

Association of the INS VNTR with size at birth. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Nat Genet (1998) 2.49

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32

APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A (1996) 2.18

Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy (2008) 1.97

A new human genetic resource: a DNA bank established as part of the Avon longitudinal study of pregnancy and childhood (ALSPAC). Eur J Hum Genet (2000) 1.92

Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med (1990) 1.85

Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci U S A (1999) 1.84

Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res (1994) 1.82

Starch branching enzymes belonging to distinct enzyme families are differentially expressed during pea embryo development. Plant J (1995) 1.68

Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res (1995) 1.67

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer (1995) 1.65

Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res (1994) 1.64

A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med (1986) 1.53

Genomic organization of the human PMS2 gene family. Genomics (1995) 1.50

Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol (2001) 1.47

Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45

Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol (1998) 1.45

Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer (2008) 1.43

Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40

Prognostic significance of HLA-DR antigen in dysplasia, carcinoma in situ and invasive carcinoma of the gallbladder. East Afr Med J (2003) 1.40

High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. J Clin Oncol (1997) 1.34

Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma. J Clin Oncol (1998) 1.32

Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30

Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol (1998) 1.29

A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma. Cancer (1989) 1.27

Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24

Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2012) 1.23

Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology (1995) 1.23

Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22

GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'. Allergy (2009) 1.22

Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy. J Clin Oncol (1995) 1.20

Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy (2008) 1.20

Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19

Branchial cysts. A report of 4 cases. Acta Dermatovenerol Alp Pannonica Adriat (2006) 1.19

Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76  TeV. Phys Rev Lett (2012) 1.19

Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res (1999) 1.19

Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia. Leukemia (2011) 1.18

APC gene mutations in the mutation cluster region are rare in esophageal cancers. Gastroenterology (1994) 1.14

Myxoid liposarcoma. Experience with chemotherapy. Cancer (1994) 1.13

Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12

First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11

Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7  TeV. Phys Rev Lett (2012) 1.10

Retracted NCL-CD30 staining of epithelial cells in the basal germinative layer of the epidermis and epithelial buds during foetal skin development. Clin Exp Med (2005) 1.09

Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol (1987) 1.09

ATR mediates cisplatin resistance in a p53 genotype-specific manner. Oncogene (2011) 1.09

Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09

Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08

Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08

Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2007) 1.07

Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07

The ossified hyoid apparatus--morphology, interpretation, clinical and functional significance. Presentation of a rare case and highlights of the literature. Anat Anz (1988) 1.06

Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06

Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy (2006) 1.05

Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04

Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha. Ann Oncol (1996) 1.03

Search for long-lived massive charged particles in 1.96 TeV pp collisions. Phys Rev Lett (2009) 1.03

Primary gastric Hodgkin's lymphoma: a case report and review of the literature. Leuk Lymphoma (2005) 1.02

Pilot study of vitaxin--an angiogenesis inhibitor-in patients with advanced leiomyosarcomas. Cancer (2001) 1.01

Analysis of masked mutations in familial adenomatous polyposis. Proc Natl Acad Sci U S A (1999) 1.01

VEGF trap as a novel antiangiogenic treatment currently in clinical trials for cancer and eye diseases, and VelociGene- based discovery of the next generation of angiogenesis targets. Cold Spring Harb Symp Quant Biol (2005) 1.01

Phase II study of paclitaxel in patients with previously treated osteosarcoma and its variants. Cancer (1996) 1.00

Observation of Bs(0)-Bs(0) oscillations. Phys Rev Lett (2006) 1.00

Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC. Phys Rev Lett (2011) 0.99

Measurement of the inclusive jet cross section in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.98

Experimental models that mimic the differentiation and dedifferentiation of vascular cells. Circulation (1992) 0.98

10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancer. Hum Pathol (2000) 0.98

Ectopic production of the beta-subunit of human chorionic gonadotropin in osteosarcoma. Arch Pathol Lab Med (1989) 0.98

Search for neutral minimal supersymmetric standard model Higgs bosons decaying to tau pairs in pp collisions at √s=7 TeV. Phys Rev Lett (2011) 0.97

Expression of HLA-DR antigen and characterization of the lymphocytic infiltrate in normal mucosa, tubulo-villous adenoma and invasive carcinoma of the colon. Chirurgia (Bucur) (2005) 0.97